...
首页> 外文期刊>Chest >Successful Polymyxin B Hemoperfusion Treatment Associated With Serial Reduction of Serum Anti-CADM-140/MDA5 Antibody Levels in Rapidly Progressive Interstitial Lung Disease With Amyopathic Dermatomyositis
【24h】

Successful Polymyxin B Hemoperfusion Treatment Associated With Serial Reduction of Serum Anti-CADM-140/MDA5 Antibody Levels in Rapidly Progressive Interstitial Lung Disease With Amyopathic Dermatomyositis

机译:快速多发性间质性肺病合并肌原性皮肌炎的血清多药毒素B血液灌流治疗成功与血清抗CADM-140 / MDA5抗体水平的连续降低相关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Amyopathic dermatomyositis is occasionally accompanied by fatal, treatment-resistant, rapidly progressive interstitial lung disease (RP-ILD).
机译:肌无力皮肌炎有时伴有致命的,对治疗有抵抗力的,快速进行性间质性肺病(RP-ILD)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号